ReviewFrontiers in medicine2026
Therapeutic potential of stem cells in addressing female infertility: recent progress and prospective developments.
Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Female infertility often results from ovarian insufficiency, endometrial damage, metabolic disorders, and treatment-induced reproductive decline. The regenerative benefits of emerging stem cell-based therapies are achieved through paracrine signaling, immunomodulation, angiogenesis, and anti-fibrotic effects. Preclinical and early clinical studies have shown that mesenchymal, pluripotent, embryonic, and reproductive progenitor cells, and their extracellular vesicles, can rescue ovarian function and improve endometrial receptivity, hormonal profiles, and follicular profiles. Although these are promising results, there are still issues with standardization, safety, and ethics. Further technological development and carefully designed clinical trials are the keys to successful translation. This review also demonstrates the underlying mechanisms, recent translational advances, and emerging technologies, as well as the need for standardized protocols and clinical validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.